Florida Senate - 2005 SENATOR AMENDMENT
Bill No. CS for SB 1180
Barcode 632916
CHAMBER ACTION
Senate House
.
.
1 5/AD/2R .
05/02/2005 06:22 PM .
2 .
.
3 .
.
4 ______________________________________________________________
5
6
7
8
9
10 ______________________________________________________________
11 Senator Peaden moved the following amendment:
12
13 Senate Amendment (with title amendment)
14 On page 3, line 18, through
15 page 4, line 6, delete those lines
16
17 and insert:
18 Section 3. Subsection (2) of section 458.331, Florida
19 Statutes, is amended, and subsection (11) is added to that
20 section, to read:
21 458.331 Grounds for disciplinary action; action by the
22 board and department.--
23 (2) The board may enter an order denying licensure or
24 imposing any of the penalties in s. 456.072(2) against any
25 applicant for licensure or licensee who is found guilty of
26 violating any provision of subsection (1) of this section or
27 who is found guilty of violating any provision of s.
28 456.072(1). A probable cause panel considering disciplinary
29 action against a physician assistant pursuant to s. 456.073
30 shall include a licensed physician assistant designated by the
31 Council on Physician Assistants. In determining what action is
1
2:23 PM 05/02/05 s1180c1c-02-25g
Florida Senate - 2005 SENATOR AMENDMENT
Bill No. CS for SB 1180
Barcode 632916
1 appropriate, the board must first consider what sanctions are
2 necessary to protect the public or to compensate the patient.
3 Only after those sanctions have been imposed may the
4 disciplining authority consider and include in the order
5 requirements designed to rehabilitate the physician. All costs
6 associated with compliance with orders issued under this
7 subsection are the obligation of the physician.
8 (11) If the department learns that a drug, as defined
9 under s. 499.003(17), which has not been approved by the
10 United States Food and Drug Administration for human use, has
11 been sold to identified health care providers in this state
12 and licensed under this chapter, the department shall
13 immediately notify the providers by certified mail of the
14 status of the drug as an unapproved product. The department
15 shall also post the information on its website to advise other
16 providers and consumers of the unapproved status of the drug.
17
18
19 ================ T I T L E A M E N D M E N T ===============
20 And the title is amended as follows:
21 On page 1, line 10, after the semicolon,
22
23 insert:
24 requiring the Department of Health to notify
25 health care providers if the department learns
26 that a drug that has not been approved by the
27 United States Food and Drug Administration for
28 human use has been sold to identified health
29 care providers in this state;
30
31
2
2:23 PM 05/02/05 s1180c1c-02-25g